| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |